{"version":"1.0","provider_name":"MedCity INVEST PharmaTech","provider_url":"https:\/\/events.medcitynews.com\/invest-pharmatech","author_name":"eclements","author_url":"https:\/\/events.medcitynews.com\/invest-pharmatech\/author\/eclements\/","title":"Michael Doherty - MedCity INVEST PharmaTech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"on6E8NFXLz\"><a href=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/michael-doherty\/\">Michael Doherty<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/michael-doherty\/embed\/#?secret=on6E8NFXLz\" width=\"600\" height=\"338\" title=\"&#8220;Michael Doherty&#8221; &#8212; MedCity INVEST PharmaTech\" data-secret=\"on6E8NFXLz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/events.medcitynews.com\/invest-pharmatech\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/events.medcitynews.com\/uploads\/sites\/3\/2016\/06\/doherty2.jpg","thumbnail_width":200,"thumbnail_height":200,"description":"Michael Doherty is currently working 50% for Roche\/Genentech and 50% for Foundation\u00a0Medicine in 2 related and synergistic roles. He leads the strategic innovation team in\u00a0Roche Pharma Development, which is focused on the transformation of the drug\u00a0development process to ensure the future sustainability of drug development. In\u00a0addition, he is working as an executive adviser to Foundation&hellip;"}